Simplify Propel Opportunities ETF holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Simplify Propel Opportunities ETF SURI
Morningstar’s Analysis SURI
Will SURI outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 162.2
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
United States Treasury Bills | 84.05 | 64M | Government |
Plains GP Holdings LP Class A | 43.19 | 33M | Energy |
Achieve Life Sciences Inc | 9.88 | 8M | Healthcare |
Achieve Life Sciences ([Wts/Rts]) | 6.45 | 5M | — |
Delcath Systems Inc | 4.72 | 4M | Healthcare |
Milestone Pharmaceuticals Inc | 3.80 | 3M | Healthcare |
Corcept Therapeutics Inc | 3.11 | 2M | Healthcare |
Collegium Pharmaceutical Inc | 2.67 | 2M | Healthcare |
Phathom Pharmaceuticals Inc Ordinary shares | 2.38 | 2M | Healthcare |
Abeona Therapeutics Inc | 1.90 | 1M | Healthcare |